A 26-year-old woman presents to the emergency department with a 2-day history of bleeding gums and persistent oozing from a small cut on her finger. She also reports feeling unusually fatigued and has had a low-grade fever. On physical examination, she has multiple ecchymoses and petechiae. Laboratory studies show a white blood cell count of 12,000/μL, hemoglobin of 8.5 g/dL, and a platelet count of 24,000/μL. A peripheral blood smear reveals numerous immature myeloid cells with stacked Auer rods. Coagulation studies show a prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), with a very low fibrinogen level.
Which of the following is the most appropriate immediate treatment to initiate in this patient, even before cytogenetic confirmation?
The correct answer is:
A) All-trans retinoic acid (ATRA)
This patient has acute promyelocytic leukemia (APL), a unique subtype of acute myelogenous leukemia (AML) characterized by the t(15;17) translocation. This translocation creates the PML-RARA fusion protein, which acts as a dominant negative repressor of the retinoic acid receptor. This locks myeloid cells in the promyelocyte stage, preventing them from maturing into functional neutrophils. APL is a medical emergency because promyelocytes contain primary granules that, when released, trigger severe disseminated intravascular coagulation (DIC). This explains the patient's low fibrinogen and oozing.
All-trans retinoic acid (ATRA; tretinoin) is a derivative of vitamin A. It binds to the altered RARA receptor and forces the malignant promyelocytes to differentiate into mature neutrophils. By inducing differentiation rather than immediate cell lysis, ATRA rapidly reduces the risk of fatal coagulopathy. In modern practice, it is often combined with arsenic trioxide (ATO) for a highly effective, non-chemotherapeutic cure.
Answer choice B: Antibiotics and platelets, is incorrect. While supportive care is necessary, it does not address the underlying cause of the DIC. ATRA must be started immediately upon clinical suspicion to stop the procoagulant state.
Answer choice C: 7+3 regimen, is incorrect. While this is the standard induction therapy for most types of AML, starting intensive chemotherapy in an APL patient before stabilization with ATRA can worsen DIC by causing a massive release of granules from lysed promyelocytes.
Answer choice D: Imatinib, is incorrect. Imatinib is a tyrosine kinase inhibitor used to treat chronic myelogenous leukemia (CML) by targeting the BCR-ABL1 protein. It has no role in the treatment of APL.
Answer choice E: Plasmapheresis, is incorrect. This is the treatment for thrombotic, thrombocytopenic purpura (TTP). While TTP also features a consumption of platelets, it would not explain the low fibrinogen or the presence of blasts and Auer rods on the smear.
Key Learning Point
Acute promyeloctic leukemia is a medical emergency because promyelocytes can trigger severe DIC. All-trans retinoic acid rapidly reduces the risk of fatal coagulopathy.
